Cells · 2020 · 22 citations · 28 references
Life SciencesImmunologyPathologyImmunopathologyInflammationInnate ImmunityCell-mediated ImmunityCellular Immune ResponsesCirrhosisHepatic PathophysiologyInflammatory SignalingLiver DiseaseAntigen Presenting CellsCd4 Positive T Cell ResponsesCd4 Positive T CellsCd4 T Cell ActivationLiver ImmunologySinusoidal Endothelial Cell FunctionSinusoidal Endothelial FunctionT Cell Responses To Bacterial Infection
Hepatic immune function is compromised during cirrhosis. This study investigated the immune features of liver sinusoidal endothelial cells (LSECs) in two experimental models of cirrhosis. Dendritic cells, hepatic macrophages, and LSECs were isolated from carbon tetrachloride and bile duct-ligated rats. Gene expression of innate receptors, bacterial internalization, co-stimulatory molecules induction, and CD4+ T cell activation and differentiation were evaluated. Induced bacterial peritonitis and norfloxacin protocols on cirrhotic rats were also carried out. LSECs demonstrated an active immunosurveillance profile, as shown by transcriptional modulation of different scavenger and cell-adhesion genes, and their contribution to bacterial internalization. LSECs significantly increased their expression of CD40 and CD80 and stimulated CD4+ T cell activation marker CD71 in both models. The pro-inflammatory Th17 subset was expanded in CCl4-derived LSECs co-cultures. In the bile duct ligation (BDL) model, CD4+ T cell differentiation only occurred under induced bacterial peritonitis conditions. Differentiated pro-inflammatory Th cells by LSECs in both experimental models were significantly reduced with norfloxacin treatment, whereas Foxp3 tolerogenic Th CD4+ cells were expanded. Conclusion: LSECs’ participation in the innate-adaptive immune progression, their ability to stimulate pro-inflammatory CD4+ T cells expansion during liver damage, and their target role in norfloxacin-induced immunomodulation granted a specific competence to this cell population in cirrhosis.
28
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki, Samuele De Minicis, Christoph H. Österreicher et al. · Nature Medicine · 2007 · 1.9K citations
Characterization of fecal microbial communities in patients with liver cirrhosis
Yanfei Chen, Fengling Yang, Haifeng Lu et al. · Hepatology · 2011 · 1K citations · Full text
The interleukin-17 pathway is involved in human alcoholic liver disease # †
Arnaud Lemmers, Christophe Moreno, Thierry Gustot et al. · Hepatology · 2008 · 385 citations
Medicine, Immunology, Pathology +17